Table of Contents Chapter 1 Overview of Nonsteroidal Antiinflammatory Drugs 1.1 Definition of Nonsteroidal Antiinflammatory Drugs in This Report 1.2 Commercial Types of Nonsteroidal Antiinflammatory Drugs 1.2.1 Oral 1.2.2 Injection 1.3 Downstream Application of Nonsteroidal Antiinflammatory Drugs 1.3.1 Osteoarthritis 1.3.2 Muscle Aches 1.3.3 Backaches 1.3.4 Dental Pain 1.3.5 Others 1.4 Development History of Nonsteroidal Antiinflammatory Drugs 1.5 Market Status and Trend of Nonsteroidal Antiinflammatory Drugs 2013-2023 1.5.1 Global Nonsteroidal Antiinflammatory Drugs Market Status and Trend 2013-2023 1.5.2 Regional Nonsteroidal Antiinflammatory Drugs Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Nonsteroidal Antiinflammatory Drugs 2013-2017 2.2 Sales Market of Nonsteroidal Antiinflammatory Drugs by Regions 2.2.1 Sales Volume of Nonsteroidal Antiinflammatory Drugs by Regions 2.2.2 Sales Value of Nonsteroidal Antiinflammatory Drugs by Regions 2.3 Production Market of Nonsteroidal Antiinflammatory Drugs by Regions 2.4 Global Market Forecast of Nonsteroidal Antiinflammatory Drugs 2018-2023 2.4.1 Global Market Forecast of Nonsteroidal Antiinflammatory Drugs 2018-2023 2.4.2 Market Forecast of Nonsteroidal Antiinflammatory Drugs by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Nonsteroidal Antiinflammatory Drugs by Types 3.2 Sales Value of Nonsteroidal Antiinflammatory Drugs by Types 3.3 Market Forecast of Nonsteroidal Antiinflammatory Drugs by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Nonsteroidal Antiinflammatory Drugs by Downstream Industry 4.2 Global Market Forecast of Nonsteroidal Antiinflammatory Drugs by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Nonsteroidal Antiinflammatory Drugs Market Status by Countries 5.1.1 North America Nonsteroidal Antiinflammatory Drugs Sales by Countries (2013-2017) 5.1.2 North America Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2013-2017) 5.1.3 United States Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 5.1.4 Canada Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 5.1.5 Mexico Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 5.2 North America Nonsteroidal Antiinflammatory Drugs Market Status by Manufacturers 5.3 North America Nonsteroidal Antiinflammatory Drugs Market Status by Type (2013-2017) 5.3.1 North America Nonsteroidal Antiinflammatory Drugs Sales by Type (2013-2017) 5.3.2 North America Nonsteroidal Antiinflammatory Drugs Revenue by Type (2013-2017) 5.4 North America Nonsteroidal Antiinflammatory Drugs Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Nonsteroidal Antiinflammatory Drugs Market Status by Countries 6.1.1 Europe Nonsteroidal Antiinflammatory Drugs Sales by Countries (2013-2017) 6.1.2 Europe Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2013-2017) 6.1.3 Germany Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 6.1.4 UK Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 6.1.5 France Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 6.1.6 Italy Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 6.1.7 Russia Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 6.1.8 Spain Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 6.1.9 Benelux Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 6.2 Europe Nonsteroidal Antiinflammatory Drugs Market Status by Manufacturers 6.3 Europe Nonsteroidal Antiinflammatory Drugs Market Status by Type (2013-2017) 6.3.1 Europe Nonsteroidal Antiinflammatory Drugs Sales by Type (2013-2017) 6.3.2 Europe Nonsteroidal Antiinflammatory Drugs Revenue by Type (2013-2017) 6.4 Europe Nonsteroidal Antiinflammatory Drugs Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Status by Countries 7.1.1 Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Countries (2013-2017) 7.1.2 Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2013-2017) 7.1.3 China Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 7.1.4 Japan Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 7.1.5 India Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 7.1.6 Southeast Asia Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 7.1.7 Australia Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 7.2 Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Status by Manufacturers 7.3 Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Status by Type (2013-2017) 7.3.1 Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Type (2013-2017) 7.3.2 Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue by Type (2013-2017) 7.4 Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Nonsteroidal Antiinflammatory Drugs Market Status by Countries 8.1.1 Latin America Nonsteroidal Antiinflammatory Drugs Sales by Countries (2013-2017) 8.1.2 Latin America Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2013-2017) 8.1.3 Brazil Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 8.1.4 Argentina Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 8.1.5 Colombia Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 8.2 Latin America Nonsteroidal Antiinflammatory Drugs Market Status by Manufacturers 8.3 Latin America Nonsteroidal Antiinflammatory Drugs Market Status by Type (2013-2017) 8.3.1 Latin America Nonsteroidal Antiinflammatory Drugs Sales by Type (2013-2017) 8.3.2 Latin America Nonsteroidal Antiinflammatory Drugs Revenue by Type (2013-2017) 8.4 Latin America Nonsteroidal Antiinflammatory Drugs Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Status by Countries 9.1.1 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2013-2017) 9.1.3 Middle East Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 9.1.4 Africa Nonsteroidal Antiinflammatory Drugs Market Status (2013-2017) 9.2 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Status by Manufacturers 9.3 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Type (2013-2017) 9.3.2 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue by Type (2013-2017) 9.4 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Nonsteroidal Antiinflammatory Drugs 10.1 Global Economy Situation and Trend Overview 10.2 Nonsteroidal Antiinflammatory Drugs Downstream Industry Situation and Trend Overview Chapter 11 Nonsteroidal Antiinflammatory Drugs Market Competition Status by Major Manufacturers 11.1 Production Volume of Nonsteroidal Antiinflammatory Drugs by Major Manufacturers 11.2 Production Value of Nonsteroidal Antiinflammatory Drugs by Major Manufacturers 11.3 Basic Information of Nonsteroidal Antiinflammatory Drugs by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Nonsteroidal Antiinflammatory Drugs Major Manufacturer 11.3.2 Employees and Revenue Level of Nonsteroidal Antiinflammatory Drugs Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Nonsteroidal Antiinflammatory Drugs Major Manufacturers Introduction and Market Data 12.1 Sanofi S.A. 12.1.1 Company profile 12.1.2 Representative Nonsteroidal Antiinflammatory Drugs Product 12.1.3 Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin of Sanofi S.A. 12.2 Novartis AG 12.2.1 Company profile 12.2.2 Representative Nonsteroidal Antiinflammatory Drugs Product 12.2.3 Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin of Novartis AG 12.3 GlaxoSmithKline PLC 12.3.1 Company profile 12.3.2 Representative Nonsteroidal Antiinflammatory Drugs Product 12.3.3 Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline PLC 12.4 Pfizer 12.4.1 Company profile 12.4.2 Representative Nonsteroidal Antiinflammatory Drugs Product 12.4.3 Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin of Pfizer 12.5 DOMESCO 12.5.1 Company profile 12.5.2 Representative Nonsteroidal Antiinflammatory Drugs Product 12.5.3 Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin of DOMESCO Chapter 13 Upstream and Downstream Market Analysis of Nonsteroidal Antiinflammatory Drugs 13.1 Industry Chain of Nonsteroidal Antiinflammatory Drugs 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Nonsteroidal Antiinflammatory Drugs 14.1 Cost Structure Analysis of Nonsteroidal Antiinflammatory Drugs 14.2 Raw Materials Cost Analysis of Nonsteroidal Antiinflammatory Drugs 14.3 Labor Cost Analysis of Nonsteroidal Antiinflammatory Drugs 14.4 Manufacturing Expenses Analysis of Nonsteroidal Antiinflammatory Drugs Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Oral Table Advantage and Disadvantage of Injection Table Sales Volume of Nonsteroidal Antiinflammatory Drugs by Regions 2013-2017 Table Sales Value of Nonsteroidal Antiinflammatory Drugs by Regions 2013-2017 Table Production Volume of Nonsteroidal Antiinflammatory Drugs by Regions 2013-2017 Table Global Sales Volume of Nonsteroidal Antiinflammatory Drugs by Regions 2018-2023 Table Global Sales Value of Nonsteroidal Antiinflammatory Drugs by Regions 2018-2023 Table Global Production Volume of Nonsteroidal Antiinflammatory Drugs by Regions 2018-2023 Table Sales Volume of Nonsteroidal Antiinflammatory Drugs by Types 2013-2017 Table Sales Value of Nonsteroidal Antiinflammatory Drugs by Types 2013-2017 Table Sales Volume Forecast of Nonsteroidal Antiinflammatory Drugs by Types 2018-2023 Table Sales Value Forecast of Nonsteroidal Antiinflammatory Drugs by Types 2018-2023 Table Sales Volume of Nonsteroidal Antiinflammatory Drugs by Downstream Industry 2013-2017 Table Sales Volume Forecast of Nonsteroidal Antiinflammatory Drugs by Downstream Industry 2018-2023 Table North America Nonsteroidal Antiinflammatory Drugs Sales by Countries (2013-2017) Table North America Nonsteroidal Antiinflammatory Drugs Sales Share by Countries (2013-2017) Table North America Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2013-2017) Table North America Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Countries (2013-2017) Table North America Nonsteroidal Antiinflammatory Drugs Sales by Type (2013-2017) Table North America Nonsteroidal Antiinflammatory Drugs Sales Share by Type (2013-2017) Table North America Nonsteroidal Antiinflammatory Drugs Revenue by Type (2013-2017) Table North America Nonsteroidal Antiinflammatory Drugs Revenue Share by Type (2013-2017) Table North America Nonsteroidal Antiinflammatory Drugs Sales by Downstream Industry (2013-2017) Table North America Nonsteroidal Antiinflammatory Drugs Sales Share by Downstream Industry (2013-2017) Table Europe Nonsteroidal Antiinflammatory Drugs Sales by Countries (2013-2017) Table Europe Nonsteroidal Antiinflammatory Drugs Sales Share by Countries (2013-2017) Table Europe Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2013-2017) Table Europe Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Countries (2013-2017) Table Europe Nonsteroidal Antiinflammatory Drugs Sales by Type (2013-2017) Table Europe Nonsteroidal Antiinflammatory Drugs Sales Share by Type (2013-2017) Table Europe Nonsteroidal Antiinflammatory Drugs Revenue by Type (2013-2017) Table Europe Nonsteroidal Antiinflammatory Drugs Revenue Share by Type (2013-2017) Table Europe Nonsteroidal Antiinflammatory Drugs Sales by Downstream Industry (2013-2017) Table Europe Nonsteroidal Antiinflammatory Drugs Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Countries (2013-2017) Table Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Share by Countries (2013-2017) Table Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2013-2017) Table Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Countries (2013-2017) Table Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Type (2013-2017) Table Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Share by Type (2013-2017) Table Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue by Type (2013-2017) Table Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue Share by Type (2013-2017) Table Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Downstream Industry (2013-2017) Table Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Share by Downstream Industry (2013-2017) Table Latin America Nonsteroidal Antiinflammatory Drugs Sales by Countries (2013-2017) Table Latin America Nonsteroidal Antiinflammatory Drugs Sales Share by Countries (2013-2017) Table Latin America Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2013-2017) Table Latin America Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Countries (2013-2017) Table Latin America Nonsteroidal Antiinflammatory Drugs Sales by Type (2013-2017) Table Latin America Nonsteroidal Antiinflammatory Drugs Sales Share by Type (2013-2017) Table Latin America Nonsteroidal Antiinflammatory Drugs Revenue by Type (2013-2017) Table Latin America Nonsteroidal Antiinflammatory Drugs Revenue Share by Type (2013-2017) Table Latin America Nonsteroidal Antiinflammatory Drugs Sales by Downstream Industry (2013-2017) Table Latin America Nonsteroidal Antiinflammatory Drugs Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Regions (2013-2017) Table Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Share by Regions (2013-2017) Table Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue by Regions (2013-2017) Table Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Type (2013-2017) Table Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Share by Type (2013-2017) Table Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue by Type (2013-2017) Table Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue Share by Type (2013-2017) Table Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Downstream Industry (2013-2017) Table Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Share by Downstream Industry (2013-2017) Table Production Volume of Nonsteroidal Antiinflammatory Drugs by Major Manufacturers 2013-2017 Table Production Value of Nonsteroidal Antiinflammatory Drugs by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Nonsteroidal Antiinflammatory Drugs Major Manufacturer Table Employees and Revenue Level of Nonsteroidal Antiinflammatory Drugs Major Manufacturer Table Representative Nonsteroidal Antiinflammatory Drugs Product One of Sanofi S.A. Table Representative Nonsteroidal Antiinflammatory Drugs Product Two of Sanofi S.A. Table Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin of Sanofi S.A. 2013-2017 Table Representative Nonsteroidal Antiinflammatory Drugs Product One of Novartis AG Table Representative Nonsteroidal Antiinflammatory Drugs Product Two of Novartis AG Table Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin of Novartis AG 2013-2017 Table Representative Nonsteroidal Antiinflammatory Drugs Product One of GlaxoSmithKline PLC Table Representative Nonsteroidal Antiinflammatory Drugs Product Two of GlaxoSmithKline PLC Table Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline PLC 2013-2017 Table Representative Nonsteroidal Antiinflammatory Drugs Product One of Pfizer Table Representative Nonsteroidal Antiinflammatory Drugs Product Two of Pfizer Table Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Nonsteroidal Antiinflammatory Drugs Product One of DOMESCO Table Representative Nonsteroidal Antiinflammatory Drugs Product Two of DOMESCO Table Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin of DOMESCO 2013-2017